Your browser doesn't support javascript.
loading
EZH2: Its regulation and roles in immune disturbance of SLE.
Yang, Yiying; Liu, Ke; Liu, Meidong; Zhang, Huali; Guo, Muyao.
Afiliación
  • Yang Y; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, China.
  • Liu K; Department of Pathophysiology, School of Basic Medicine Science, Central South University, Changsha, China.
  • Liu M; Sepsis Translational Medicine Key Lab of Hunan Province, China.
  • Zhang H; Department of Pathophysiology, School of Basic Medicine Science, Central South University, Changsha, China.
  • Guo M; Sepsis Translational Medicine Key Lab of Hunan Province, China.
Front Pharmacol ; 13: 1002741, 2022.
Article en En | MEDLINE | ID: mdl-36313363
ABSTRACT
The pathogenesis of systemic lupus erythematosus (SLE) is related to immune homeostasis imbalance. Epigenetic mechanisms have played a significant role in breaking immune tolerance. Enhancer of zeste homolog 2 (EZH2), the specific methylation transferase of lysine at position 27 of histone 3, is currently found to participate in the pathogenesis of SLE through affecting multiple components of the immune system. This review mainly expounds the mechanisms underlying EZH2-mediated disruption of immune homeostasis in SLE patients, hoping to provide new ideas in the pathogenesis of SLE and new targets for future treatment.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China